Patents by Inventor Chae Lim
Chae Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11966919Abstract: Various example embodiments of the disclosure relate to an electronic device and a wireless communication connection control method thereof.Type: GrantFiled: March 14, 2022Date of Patent: April 23, 2024Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Min-Ho Kang, Jinhyun Park, Ye-Ji Yoon, Jun-Hak Lim, Wontae Chae, Jongmu Choi, Bokun Choi, Doo-Suk Kang, Sun-Kee Lee, Moonsoo Kim, Eun Jung Hyun
-
Publication number: 20240035502Abstract: A fastener for use in joining dissimilar materials manufactured by the process of producing the fastener with an external surface that forms an electrically insulating oxide layer when subjected to oxidation and, after manufacture and prior to use, subjecting the fastener to a pre-oxidation process to grow the desired oxide layer in situ on the external surface of the fastener. The present invention also provides a dissimilar material joint in which the pre-oxidized fastener is used to mechanically join dissimilar materials with the oxide layer electrically insulating the fastener from at least one of the dissimilar materials. The fastener may be a rivet used in friction self-piercing riveting (F-SPR). The fastener may be fabricated from an alloy capable of forming Al2O3 or Cr2O3 by thermal oxidation. The fastener may be pre-coated with Al or Cr that functions as a seed layer to form Al2O3 or Cr2O3.Type: ApplicationFiled: October 3, 2023Publication date: February 1, 2024Inventors: Yong Chae Lim, Ji Heon Jun, Michael P. Brady, Zhili Feng
-
Patent number: 11808297Abstract: A fastener for use in joining dissimilar materials manufactured by the process of producing the fastener with an external surface that forms an electrically insulating oxide layer when subjected to oxidation and, after manufacture and prior to use, subjecting the fastener to a pre-oxidation process to grow the desired oxide layer in situ on the external surface of the fastener. The present invention also provides a dissimilar material joint in which the pre-oxidized fastener is used to mechanically join dissimilar materials with the oxide layer electrically insulating the fastener from at least one of the dissimilar materials. The fastener may be a rivet used in friction self-piercing riveting (F-SPR). The fastener may be fabricated from an alloy capable of forming Al2O3 or Cr2O3 by thermal oxidation. The fastener may be pre-coated with Al or Cr that functions as a seed layer to form Al2O3 or Cr2O3.Type: GrantFiled: January 29, 2021Date of Patent: November 7, 2023Assignee: UT-Battelle, LLCInventors: Yong Chae Lim, Ji Heon Jun, Michael P. Brady, Zhili Feng
-
Patent number: 11713344Abstract: A novel peptide analog of acylated oxyntomodulin and its uses are disclosed. A pharmaceutical composition containing the novel peptide analog is useful and effective for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptide analog and a composition containing the peptide analog are superior to those of wild-type oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition containing the peptide analog is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.Type: GrantFiled: August 24, 2021Date of Patent: August 1, 2023Assignee: DONG-A ST CO., LTD.Inventors: Jae-Sung Yang, Kyung-Seok Lee, Yu-Na Chae, Gye-Rim Baek, Tae-Hyoung Kim, Ill-Hun Jung, Chae-Lim Ryu, Weon-Bin Im
-
Publication number: 20230220035Abstract: A novel long-acting acylated oxyntomodulin peptide analogue having dual agonism on GLP-1 and glucagon receptors (dual GLP-1R/GlucagonR agonism) and a pharmaceutical composition including the same are disclosed. The novel long-acting acylated oxyntomodulin peptide analogue and the composition are useful for the prevention and treatment of obesity and overweight, or non-insulin-dependent diabetes accompanied by obesity and overweight. The acylated oxyntomodulin peptide analog has dual agonism for GLP-1/glucagon receptors and has an excellent increased in vivo half-life, and the pharmaceutical composition containing the same is useful for the treatment of metabolic diseases such as obesity and diabetes.Type: ApplicationFiled: April 15, 2021Publication date: July 13, 2023Applicant: DONG-A ST CO., LTD.Inventors: Jae-Sung YANG, Kyung-Seok LEE, Yu-Na CHAE, Tae-Hyoung KIM, Ill-Hun JUNG, Chae-Lim RYU, Dae-Young LEE
-
Publication number: 20220259199Abstract: The present invention relates to a novel heterocycle derivative, a salt thereof, or an isomer thereof. More specifically, the present invention relates to a novel heterocycle derivative effective for the therapy for hair loss such as androgenic alopecia and alopecia areata and having an excellent preventive effect of hair loss, a salt or isomer thereof, and a composition comprising same as an effective ingredient for prevention of hair loss.Type: ApplicationFiled: May 2, 2019Publication date: August 18, 2022Inventors: Woo Sang HONG, Joo Young CHA, Sun Ea CHOI, Isak IM, Chi-Ho YUN, Jae Ho JANG, Chae Lim JUNG, Sei Ho CHIN, Jiknyeo KIM, Joongsoo KIM, Sang Hak LEE
-
Publication number: 20220243749Abstract: A fastener for use in joining dissimilar materials manufactured by the process of producing the fastener with an external surface that forms an electrically insulating oxide layer when subjected to oxidation and, after manufacture and prior to use, subjecting the fastener to a pre-oxidation process to grow the desired oxide layer in situ on the external surface of the fastener. The present invention also provides a dissimilar material joint in which the pre-oxidized fastener is used to mechanically join dissimilar materials with the oxide layer electrically insulating the fastener from at least one of the dissimilar materials. The fastener may be a rivet used in friction self-piercing riveting (F-SPR). The fastener may be fabricated from an alloy capable of forming Al2O3 or Cr2O3 by thermal oxidation. The fastener may be pre-coated with Al or Cr that functions as a seed layer to form Al2O3 or Cr2O3.Type: ApplicationFiled: January 29, 2021Publication date: August 4, 2022Inventors: Yong Chae Lim, Ji Heon Jun, Michael P. Brady, Zhili Feng
-
Publication number: 20220119473Abstract: A novel peptide analog of acylated oxyntomodulin and its uses are disclosed. A pharmaceutical composition containing the novel peptide analog is useful and effective for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptide analog and a composition containing the peptide analog are superior to those of wild-type oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition containing the peptide analog is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.Type: ApplicationFiled: August 24, 2021Publication date: April 21, 2022Applicant: DONG-A ST CO., LTD.Inventors: Jae-Sung YANG, Kyung-Seok LEE, Yu-Na CHAE, Gye-Rim BAEK, Tae-Hyoung KIM, Ill-Hun JUNG, Chae-Lim RYU, Weon-Bin IM
-
Patent number: 11306141Abstract: The present invention relates to an antibody against delta-like 1 homolog (Drosophila) (DLK1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, an antibody drug conjugate (ADC) comprising the same, a pharmaceutical composition for treating cancer, a composition for diagnosing cancer, and a chimeric antigen receptor (CAR) and a T-cell engager comprising the same.Type: GrantFiled: September 10, 2018Date of Patent: April 19, 2022Assignee: Y-BIOLOGICS INC.Inventors: Jung Chae Lim, Ji-Young Shin, Sunha Yoon, Sang Pil Lee, Yunseon Choi, Jisu Lee, Young-Gyu Cho, Seok Ho Yoo, Yeung chul Kim, Si Hyung Lee, Jae Eun Park, Youngja Song, Gi Sun Baek, Bum-chan Park, Young Woo Park
-
Patent number: 11253908Abstract: A method for joining dissimilar materials is provided. The method includes a solid-state joining process in which a rivet is plunged into a predrilled hole in a top workpiece. When the rivet contacts the bottom workpiece, ultrasonic vibration by oscillatory motion of a sonotrode, such as horizontal, vertical, or rotational motion, creates frictional heat at the interface between the rivet and the lower workpiece. With the aid of frictional heat and axial compression, metallurgical bonding is achieved at the interface between the rivet and the bottom sheet, while being below the melting temperature of the bottom workpiece. The sonotrode is retracted while the rivet remains.Type: GrantFiled: April 27, 2020Date of Patent: February 22, 2022Assignee: UT-BATTELLE, LLCInventors: Yong Chae Lim, Zhili Feng, Jian Chen, Xin Sun, Richard W. Davies
-
Patent number: 11248048Abstract: Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.Type: GrantFiled: August 7, 2017Date of Patent: February 15, 2022Assignee: Y-BIOLOGICS INC.Inventors: Jae Eun Park, Soo Young Kim, Hyun Mi Lee, Si Hyung Lee, Hyun Kyung Lee, Hye-Nan Kim, Jin Chui Youn, Bum-chan Park, Jung Chae Lim, Young-Gyu Cho, Young Woo Park
-
Patent number: 11236142Abstract: The present invention relates to a novel peptide analog of acylated oxyntomodulin and a pharmaceutical composition comprising the same for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptides are superior to those of natural oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition comprising said peptides is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.Type: GrantFiled: August 16, 2018Date of Patent: February 1, 2022Assignee: DONG-A ST CO., LTD.Inventors: Jae-Sung Yang, Kyung-Seok Lee, Yu-Na Chae, Gye-Rim Baek, Tae-Hyoung Kim, Ill-Hun Jung, Chae-Lim Ryu, Weon-Bin Im
-
Patent number: 11109430Abstract: A display apparatus includes a processor configured to receive device information of a portable device, which includes first information about a wireless connection between the portable device and an access point and second information about whether the portable device supports a real simultaneous dual band (RSDB), acquire device information of the display apparatus, which includes third information about a wireless connection between the display apparatus and the access point and fourth information about whether the display apparatus supports the RSDB, determine a peer-to-peer (P2P) operating channel between the display apparatus and the portable device based on the device information of the display apparatus and the device information of the portable device, and control the display apparatus to connect the display apparatus to the portable device through the determined P2P operating channel.Type: GrantFiled: August 19, 2019Date of Patent: August 31, 2021Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Jin-ho Kim, Kyeong-chae Lim, Deok-nam Kim
-
Publication number: 20210214432Abstract: The present invention relates to an antibody against delta-like 1 homolog (Drosophila) (DLK1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, an antibody drug conjugate (ADC) comprising the same, a pharmaceutical composition for treating cancer, a composition for diagnosing cancer, and a chimeric antigen receptor (CAR) and a T-cell engager comprising the same.Type: ApplicationFiled: September 10, 2018Publication date: July 15, 2021Inventors: Jung Chae Lim, Ji-Young Shin, Sunha Yoon, Sang Pil Lee, Yunseon Choi, Jisu Lee, Young-Gyu Cho, Seok Ho Yoo, Yeung chul Kim, Si Hyung Lee, Jae Eun Park, Youngja Song, Gi Sun Baek, Bum-chan Park, Young Woo Park
-
Patent number: 11019410Abstract: Disclosed is a method and apparatus that may provide predetermined partial content of content provided from a content providing server to a user terminal by controlling the partial content based on an interaction of a user or synthesizing new content with the partial content, and by displaying the controlled content or the synthesized content.Type: GrantFiled: December 7, 2018Date of Patent: May 25, 2021Assignee: NAVER WEBTOON Ltd.Inventors: Jin Jung, Seung-hun Lee, Yeojung Kim, Changgeun Song, SeungTaek Lim, Sang Hyeon Kim, Kyeongryeol Park, Hyeong Gyu Kim, Sang Min Park, Hee Jae Ahn, Kain Choi, Young-Chae Lim, Ji Ung Han
-
Publication number: 20210129207Abstract: A method for joining dissimilar materials is provided. The method includes a solid-state joining process in which a rivet is plunged into a predrilled hole in a top workpiece. When the rivet contacts the bottom workpiece, ultrasonic vibration by oscillatory motion of a sonotrode, such as horizontal, vertical, or rotational motion, creates frictional heat at the interface between the rivet and the lower workpiece. With the aid of frictional heat and axial compression, metallurgical bonding is achieved at the interface between the rivet and the bottom sheet, while being below the melting temperature of the bottom workpiece. The sonotrode is retracted while the rivet remains.Type: ApplicationFiled: April 27, 2020Publication date: May 6, 2021Inventors: Yong Chae Lim, Zhili Feng, Jian Chen, Xin Sun, Richard W. Davies
-
Patent number: 10919966Abstract: Disclosed are an antibody to human programmed cell death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer or infectious diseases containing the same.Type: GrantFiled: August 7, 2017Date of Patent: February 16, 2021Assignee: Y-BIOLOGICS INC.Inventors: Jae Eun Park, Soo A Choi, Jisu Lee, Hyun Mi Lee, Si Hyung Lee, Gi Sun Baek, Yeung Chul Kim, Bum-chan Park, Jung Chae Lim, Young-Gyu Cho, Young Woo Park
-
Publication number: 20200354425Abstract: The present invention relates to a novel peptide analog of acylated oxyntomodulin and a pharmaceutical composition comprising the same for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptides are superior to those of natural oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition comprising said peptides is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.Type: ApplicationFiled: August 16, 2018Publication date: November 12, 2020Applicant: DONG-A ST CO., LTD.Inventors: Jae-Sung YANG, Kyung-Seok LEE, Yu-Na CHAE, Gye-Rim BAEK, Tae-Hyoung KIM, Ill-Hun JUNG, Chae-Lim RYU, Weon-Bin IM
-
Publication number: 20190379854Abstract: A display apparatus includes a processor configured to receive device information of a portable device, which includes first information about a wireless connection between the portable device and an access point and second information about whether the portable device supports a real simultaneous dual band (RSDB), acquire device information of the display apparatus, which includes third information about a wireless connection between the display apparatus and the access point and fourth information about whether the display apparatus supports the RSDB, determine a peer-to-peer (P2P) operating channel between the display apparatus and the portable device based on the device information of the display apparatus and the device information of the portable device, and control the display apparatus to connect the display apparatus to the portable device through the determined P2P operating channel.Type: ApplicationFiled: August 19, 2019Publication date: December 12, 2019Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Jin-ho KIM, Kyeong-chae LIM, Deok-nam KIM
-
Patent number: 10476954Abstract: Disclosed are a communication device, a communication method, and a communication system. The communication system includes a communication device configured to determine a device to function as a group owner (GO) device from the communication device and a counterpart communication device communicating with the communication device and transmit information indicating which one of the communication device and the counterpart communication device is the GO device to the counterpart communication device, and the counterpart communication device configured to receive the information indicating which one of the communication device and the counterpart communication device is the GO device from the communication device and transmit, in response to receiving the information, a signal for agreeing to the information indicating which one of the communication device and the counterpart communication device is the GO device to the communication device.Type: GrantFiled: June 30, 2016Date of Patent: November 12, 2019Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Kyeong-chae Lim, Ki-hun Kim, Jae-sung An